Cathie Wood
ENTX icon

Cathie Wood’s Entera Bio ENTX Stock Holding History

Cathie Wood’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,744
Closed -$5K – 353
2022
Q1 		$5K Sell
1,744
-689,178
-100% -$1.65M ﹤0.01% 350
2021
Q4 		$1.95M Buy
690,922
+7,915
+1% +$29.7K 0.01% 242
2021
Q3 		$3.22M Buy
+683,007
New +$3.5M 0.01% 230

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Cathie Wood's ENTX Position: Q2 2022 in Review

Cathie Wood sold out of Entera Bio (ENTX) in Q2 2022, closing a stake of 1,744 shares — an estimated $5K sold.

Cathie Wood first reported a position in ENTX in Q3 2021 and held it in 3 quarters. The position peaked at $3.22M in Q3 2021. 10 funds tracked by Wall St. Rank hold ENTX as of Q2 2022.

  • Cathie Wood reported no remaining Entera Bio position as of Q2 2022 after selling out during the quarter.
  • Cathie Wood sold 1,744 Entera Bio shares in Q2 2022, an estimated $5K.
  • Cathie Wood first reported a position in Entera Bio in Q3 2021 and held it in 3 quarters.
  • Cathie Wood's Entera Bio position peaked at $3.22M in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Entera Bio as of Q2 2022.

Based on ARK Investment Management's 13F filing for Q2 2022, filed 11 Jul 2022.